Treatment Information


Rectal Cancer treatment details. Chemotherapy, Radiation.

Mount Vernon Cancer Centre, London, United Kingdom.

Survival: monthsCountry:United Kingdom
Toxiciy Grade:4City/State/Province:London
Treatments:Chemotherapy, RadiationHospital:Mount Vernon Cancer Centre
Date:Jan 2006


Patients: This Phase I study involved 18 patients with locally advanced rectal cancer. Twelve patients were men, six were women, and the median age was 56.8 years.

Treatment: The treatment consisted of radiation therapy and two chemotherapeutic agents: capecitabine and oxaliplatin.

Toxicity: Grade 1-4 toxicities included diarrhea, lethargy, abdominal pain, and rectal pain.

Results: The median overall survival was not reported. Five patients had a complete response to treatment.

Support: Roche Laboratories provided "study support." Roche markets and/or manufactures capecitabine.

Correspondence: Antonius A. Miller